ArticleScientific reports2026

Correction: Bevacizumab enhances overall survival in newly diagnosed glioblastoma patients with high COX-2 expression.

Irfan Kesumayadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.